Skip to main content
. 2018 May 7;7(7):e1440169. doi: 10.1080/2162402X.2018.1440169

Figure 1.

Figure 1.

Treatment plan and treatment protocol. (A) Schematic representation of the CAR-133-CD137ζ chimeric T-cell receptor cDNA plasmid, not to scale. (B) Consort flow diagram of the clinical trial. (C) One standard cycle of CART-133 treatment procedure. CART-133 treatment for non-HCC patients included a chemotherapy pre-regimen (red dashed line).